Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $1,261 - $2,664
738 Added 4.02%
19,090 $36,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $34,868 - $158,377
18,352 New
18,352 $44,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $153,568 - $649,602
-72,098 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $366,902 - $910,830
-58,424 Reduced 44.76%
72,098 $606,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $1.22 Million - $2.37 Million
82,722 Added 173.06%
130,522 $2.04 Million
Q3 2021

Nov 12, 2021

BUY
$24.31 - $33.6 $377,315 - $521,505
15,521 Added 48.08%
47,800 $1.36 Million
Q2 2021

Aug 06, 2021

SELL
$26.09 - $40.4 $287,276 - $444,844
-11,011 Reduced 25.44%
32,279 $1.1 Million
Q1 2021

May 14, 2021

BUY
$33.06 - $56.93 $1.16 Million - $1.99 Million
35,017 Added 423.27%
43,290 $1.53 Million
Q4 2020

Feb 12, 2021

BUY
$39.09 - $57.4 $323,391 - $474,870
8,273 New
8,273 $366,000
Q2 2019

Aug 20, 2019

SELL
$17.37 - $26.27 $437,550 - $661,741
-25,190 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$10.65 - $25.75 $120,611 - $291,618
-11,325 Reduced 31.01%
25,190 $590,000
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $83,775 - $148,189
-9,047 Reduced 19.86%
36,515 $372,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $459 - $1,116
61 Added 0.13%
45,562 $762,000
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $79,800 - $171,000
17,015 Added 59.73%
45,501 $213,000
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $83,795 - $106,503
10,661 Added 59.81%
28,486 $259,000
Q3 2017

Nov 15, 2017

BUY
$8.89 - $10.4 $158,464 - $185,380
17,825
17,825 $167,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.